Resilient Lifescience
PrivateLast Round
Grant
Sep 23, 2024
Est. Valuation
$5M
Total Funding Raised
$3.72M
Company Overview
Resilient Lifescience is a medical devices company developing a wearable patch that automatically detects and reverses an opioid overdose by delivering naloxone.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors, Medical AI
Business Model
B2B
Customer Profile
Hardware + Subscription, Government Contracts, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Resilient Lifescience Comps
Public and private peers based on sector, stage, and business model.
Resilient Lifescience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 23, 2024 | ||||
| Accelerator | Dec 6, 2023 | ||||
| VC Round | Feb 7, 2023 | ||||
| Pre Seed | May 16, 2022 |
Key People
Founding team and executive leadership
Resilient Lifescience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AlphaLab Health | Accelerator |
| NIH RADx | Grant |
| Richard King Mellon Foundation | VC Round |
| Tau Ventures | Pre Seed |
| Chuangxin Innovation Works | Accelerator |
Resilient Lifescience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Resilient Lifescience's valuation, stock price, and market status.
